Stephen R.D. Johnston
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Mitch Dowsett (9 shared papers)Anthony Howell (1 shared paper)Sacha J. Howell (1 shared paper)Roger A’Hern (3 shared papers)L Pyle (2 shared papers)Matthew Vaughan (2 shared papers)Tim Eisen (2 shared papers)Ian Mak (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Cancer (3 papers)Clinical Cancer Research (2 papers)The Journal of Steroid Biochemistry and Molecular Biology (2 papers)Clinical Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesHungary
In The Last Decade
Stephen R.D. Johnston
42 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 89
- Oncology 795
- Cancer Research 379
- Genetics 658
- Toxicology 39
- Molecular Biology 762
Countries citing papers authored by Stephen R.D. Johnston
This map shows the geographic impact of Stephen R.D. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R.D. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R.D. Johnston more than expected).
Fields of papers citing papers by Stephen R.D. Johnston
This network shows the impact of papers produced by Stephen R.D. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R.D. Johnston. The network helps show where Stephen R.D. Johnston may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen R.D. Johnston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 274 | |
| 2 | 2003 | 240 | |
| 3 | 2003 | 154 | |
| 4 | Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. | 1999 | 129 |
| 5 | 2003 | 112 | |
| 6 | 1997 | 111 | |
| 7 | 2001 | 105 | |
| 8 | 2005 | 69 | |
| 9 | 2005 | 67 | |
| 10 | 2005 | 52 | |
| 11 | Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. | 1999 | 49 |
| 12 | 2007 | 41 | |
| 13 | 2010 | 39 | |
| 14 | Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies. | 2001 | 38 |
| 15 | Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. | 2006 | 37 |
| 16 | 2011 | 34 | |
| 17 | 2013 | 32 | |
| 18 | 2006 | 31 | |
| 19 | 1994 | 30 | |
| 20 | 2002 | 29 |
About Stephen R.D. Johnston
Stephen R.D. Johnston is a scholar working on Oncology, Genetics, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (19 papers), HER2/EGFR in Cancer Research (17 papers), Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (4 papers), Retinoids in leukemia and cellular processes (3 papers), Genomics and Chromatin Dynamics (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Oncology (795 citations), Cancer Research (379 citations), Genetics (658 citations), Toxicology (39 citations) and Molecular Biology (762 citations). Stephen R.D. Johnston has collaborated with scholars based in United Kingdom, United States and Hungary. Frequent co-authors include Mitch Dowsett, Anthony Howell, Sacha J. Howell, Roger A’Hern, L Pyle, Matthew Vaughan, Tim Eisen, Ian Mak, Martin Gore and Chris Boshoff. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Cancer Research, The Journal of Steroid Biochemistry and Molecular Biology and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.